The European Medicines Agency (EMA) is reviewing the painkiller, Metamizol, over concerns of agranulocytosis that can seriously affects the immune system that are available in Spain and other EU countries.


Size: 4540px × 3026px
Location: madrid spain
Photo credit: © Lawrence JC Baron / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: 17th, 2024, 575mg, affects, agency, agranulocytosis, attributed, authorised, background, blister, blood, box, boxes, british, capsules, capsuls, care, cells, closeup, community, concept, concerns, countries, cure, death, deaths, dose, drug, drugs, effect, efg, ema, eu, europe, european, expat, fatal, fever, granulocytes, health, healthcare, immune, infections, june, madrid, medical, medicament, medication, medicine, medicines, metamizol, metamizole, northern, pain, painkiller, people, pharmaceutical, pharmacy, pill, pills, prescription, rationpharma, ratiopharma, red, remedy, review, risk, risks, severe, sickness, side, spain, system, tablet, teva, therapy, treating, treatment, white